Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 2020

View Archived Issues

The next pandemic: speeding development and stretching supplies

Gut repair with an iron will

Eight newly identified loci are involved in the susceptibility to cutaneous SCC, large GWAS shows

Rac1 overexpression is involved in breast cancer chemoresistance by influencing DNA damage repair

FDA authorizes phase II study of MultiStem cell therapy in trauma patients

Chinese regulatory approval granted to initiate phase II/III study of HBM-9161 in ITP

TScan and Novartis collaborate to develop novel TCR-engineered T-cell therapies

Novel hBCR/ABL1-induced zebrafish model of CML

EM2D9 antibody shows potent antitumor activity in preclinical models of endometrial cancer

New Toll-like receptor 7 agonists discovered at Bristol-Myers Squibb

Shenzhen Edk Pharmaceutical Technology patents androgen receptor antagonists

Betta Pharmaceuticals discloses new FGFR-4 inhibitors

Shanghai Ennova Biopharmaceutical describes new SSAO inhibitors

OncoImmune initiates phase III study with CD24Fc for COVID-19

New MAP3K5 inhibitors identified at XuanZhu Pharma

New ANKRD26-RET fusion gene found in papillary thyroid carcinoma

Galapagos and Ryvu establish research collaboration in inflammation

Roivant initiates pivotal trial of gimsilumab for prevention and treatment of COVID-19-related ARDS

FDA approves Jelmyto for low-grade upper tract urothelial cancer

Vir reports interim data from ongoing phase II study of VIR-2218 for chronic HBV infection

SPL-7013 demonstrates significant activity against SARS-CoV-2 in lab studies

Gilead Sciences begins phase III trial of remdesivir for the treatment of COVID-19 in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...